Screening for neurofilament inclusion disease using α-internexin immunohistochemistry

Neurology

Volumn 64, Issue 9, 2005, Pages 1658-1659

  Uchikado, Hirotake ^a   Shaw, Gerry ^b   Wang, Deng Shun ^a   Dickson, Dennis W ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERNEXIN; ALPHA SYNUCLEIN; NEUROFILAMENT PROTEIN; PARAFFIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CAUDATE NUCLEUS; CELL INCLUSION; DEGENERATIVE DISEASE; DEMENTIA; FRONTAL CORTEX; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; INSULA; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MESENCEPHALON; MULTI SYSTEM ATROPHY; NERVE CELL DEGENERATION; NEUROFILAMENT INCLUSION DISEASE; NEUROPATHOLOGY; PARIETAL LOBE; PARKINSONISM; PONS; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PUTAMEN; SCREENING; TAUOPATHY; TEMPORAL CORTEX; THALAMUS;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CARRIER PROTEINS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INTERMEDIATE FILAMENT PROTEINS; INTERMEDIATE FILAMENTS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSONIAN DISORDERS; PREDICTIVE VALUE OF TESTS; PYRAMIDAL TRACTS; TAUOPATHIES;

EID: 18144385481     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000160328.17975.9C     Document Type: Article

References (7)

1. Cairns NJ, Grossman M, Arnold SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004;63:1376-1384.
2. Cairns NJ, Uryu K, Bigio EH, et al. Alpha-internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathol (Berl) 2004;108:213-223.
3. Cairns NJ, Zhukareva V, Uryu K, et al. Alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 2004;164:2153-2161.
4. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
5. Bigio EH, Lipton AM, White CL 3rd, et al. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol 2003;29:239-253.
6. Cairns NJ, Perry RH, Jaros E, et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003;341:177-180.
7. Kaplan MP, Chin SS, Fliegner KH, et al. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J Neurosci 1990;10:2735-2748.